Display Settings:

Format

Send to:

Choose Destination
    West J Med. 1997 Feb;166(2):129-37.

    Fragile X syndrome. Molecular and clinical insights and treatment issues.

    Source

    Child Development Unit, Children's Hospital, Denver, CO 80218, USA.

    Abstract

    The fragile X syndrome is the most common inherited cause of mental retardation that is known. The prevalence of mental retardation from this syndrome ranges from 1 in 1,250 to 1 in 4,000 in the general population, although the prevalence of female carriers has been reported to be as high as 1 in 259. The discovery of the FMR1 gene mutation in 1991 has simplified diagnosis, enhanced our understanding of the spectrum of involvement in the fragile X syndrome, and stimulated research regarding the normal function of the FMR1 protein in brain development. Advances have also occurred in the treatment of the fragile X syndrome, and psychopharmacologic and educational interventions are reviewed here.

    PMID:
    9109330
    [PubMed - indexed for MEDLINE]
    PMCID:
    PMC1304031
    Free PMC Article

      Supplemental Content

      Icon for PubMed Central

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk